Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.46 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3263562 | 0.92 | F10 (0.50) | F10ABCB11F2ST14CYP3A4 | |
| SCHEMBL2995671 | 0.87 | F10 (0.59) | F10ABCB11F2ST14CYP3A4 | |
| SCHEMBL2995676 | 0.87 | F10 (0.59) | F10ABCB11F2ST14CYP3A4 | |
| SCHEMBL3681045 | 0.81 | F10 (0.47) | F10 | |
| SCHEMBL2191043 | 0.79 | F10 (0.63) | F10ABCB11F2ST14CYP3A4 | |
| SCHEMBL2191033 | 0.79 | F10 (0.63) | F10ABCB11F2ST14CYP3A4 | |
| SCHEMBL3646789 | 0.78 | F10 (0.48) | F10F2 | |
| SCHEMBL3674517 | 0.77 | F10 (0.63) | F10ABCB11F2ST14CYP3A4 | |
| SCHEMBL2233431 | 0.74 | F10 (0.67) | F10ABCB11F2ST14CYP3A4 | |
| SCHEMBL3276611 | 0.74 | F10 (0.67) | F10ABCB11F2ST14CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2167495-A1 | SUBSTITUTED OXAZOLIDINONES AND THE USE THEREOF | Bayer Schering Pharma AG (DE) | 2010-03-31 | — | — | EP | disclosed |
| WO-2008155034-A1 | SUBSTITUTED OXAZOLIDINONES AND THE USE THEREOF | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-12-24 | — | — | WO | disclosed |